ANI Pharmaceuticals
ANIP
#4819
Rank
ยฃ1.37 B
Marketcap
ยฃ61.33
Share price
-1.17%
Change (1 day)
39.77%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2025 (TTM): ยฃ1.26

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is ยฃ1.28. In 2024 the company made an earnings per share (EPS) of -ยฃ0.84.

EPS history for ANI Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)ยฃ1.26-249.76%
2024-ยฃ0.84
2022-ยฃ2.28-6.46%
2021-ยฃ2.4472.87%
2020-ยฃ1.41-476%
2019ยฃ0.38-62.12%
2018ยฃ0.99
2015ยฃ1.01-47.66%
2014ยฃ1.92-142.11%
2013-ยฃ4.56

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Jazz Pharmaceuticals
JAZZ
-ยฃ4.47-448.54%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
-ยฃ2.25-275.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.47-63.16%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Pfizer
PFE
ยฃ1.29 0.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Lannett Company
LCI
-ยฃ18.96-1,578.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-ยฃ2.54-297.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
ยฃ5.00 289.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
ยฃ5.52 330.41%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Royalty Pharma
RPRX
ยฃ1.32 3.29%๐Ÿ‡ฌ๐Ÿ‡ง UK